Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials

Alice B. Gottlieb; Jashin J. Wu; Christopher Em Griffiths; Kwaku Marfo; Elisa Muscianisi; Xiangyi Meng; Jennifer Frueh; Mark Lebwohl

doi:10.1080/09546634.2020.1832187

Article2014

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl, Kristian Reich, Christopher Em Griffiths, Kim Papp, L. Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson, Enrique Rivas, Tsen‐Fang Tsai, Norman Wasel, Stephen K. Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, C. Papavassilis

Article2016

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

Masatoshi Kudo, Masafumi Ikeda, Tadatoshi Takayama, Kazushi Numata, Namiki Izumi, Junji Furuse, Takuji Okusaka, Masumi Kadoya, Satoshi Yamashita, Yuichiro Ito, Norihiro Kokudo

Article2020

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Thomas Vanassche, Peter Verhamme, Darryl P. Leong, Deepak L. Bhatt, Olga Shestakovska, Aldo Maggioni, Keith A.A. Fox, Eva Muehlhofer, Stuart J. Connolly, Salim Yusuf, John W. Eikelboom, Jackie Bosch

Article2019

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

Andrew Alexis, Marta I. Rendon, Jonathan I. Silverberg, David M. Pariser, Benjamin Lockshin, Christopher Em Griffiths, Jamie Weisman, Andreas Wollenberg, Zhen Chen, John D. Davis, Meng Li, Laurent Eckert, Abhijit Gadkari, Brad Shumel, Ana B. Rossi, Neil M.H. Graham, Marius Ardeleanu

Article2019

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

Andrew Alexis, Marta I. Rendon, Jonathan I. Silverberg, David M. Pariser, Benjamin Lockshin, Christopher Em Griffiths, Jamie Weisman, Andreas Wollenberg, Zhen Chen, John D. Davis, Meng Li, Laurent Eckert, Abhijit Gadkari, Brad Shumel, Ana B. Rossi, Neil M.H. Graham, Marius Ardeleanu

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials

Abstract

Discussion(0)

Related publications

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials